Benitec Biopharma Inc. (BNTC)

NASDAQ: BNTC · Real-Time Price · USD

12.56

0.00 (0.00%)

At close: Aug 14, 2026, 4:00 PM EDT

12.62

+0.06 (0.48%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Benitec Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-41.54	-37.92	-21.75	-19.56	-18.21	-13.88
Depreciation & Amortization	0.48	0.4	0.34	0.38	0.39	0.42
Loss (Gain) From Sale of Investments	-	-	0	0	0.01	-0.02
Stock-Based Compensation	26.26	17.43	0.83	0.45	0.87	0.63
Other Operating Activities	-	-0.76	-	-	-	-
Change in Accounts Receivable	0	0.2	-0.18	-0.05	0	0.03
Change in Accounts Payable	-4.01	-2.38	0.94	1.36	1.09	0.06
Change in Other Net Operating Assets	-0.97	-0.55	0.41	-0.59	-0.05	-0.08
Operating Cash Flow	-19.79	-23.59	-19.4	-18.01	-15.9	-12.83
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Capital Expenditures	-0.03	-0.02	-0.18	-0	-0.01	-0.22
Investing Cash Flow	-0.03	-0.02	-0.18	-0	-0.01	-0.22

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Issuance of Common Stock	107.82	72.8	73.92	17.88	-	25.75
Other Financing Activities	-6.34	-2.32	-5.89	-1.87	-	-3.23
Financing Cash Flow	101.48	70.49	68.03	16.02	-	22.52

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Foreign Exchange Rate Adjustments	-0.23	0.05	-0.01	0.41	0.2	0.5
Net Cash Flow	81.43	46.93	48.44	-1.59	-15.71	9.97

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-19.82	-23.61	-19.58	-18.01	-15.91	-13.05
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-	-	-	-24017.33%	-21797.26%	-22123.73%
Free Cash Flow Per Share	-0.45	-0.65	-1.07	-13.00	-33.10	-51.66
Levered Free Cash Flow	-7.13	-11.46	-11.68	-10.19	-8.72	-7.28
Unlevered Free Cash Flow	-7.13	-11.46	-11.68	-10.16	-8.7	-7.28

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Change in Working Capital	-4.99	-2.73	1.17	0.71	1.04	0.01

SEC Filings: 10-K · 10-Q